196 related articles for article (PubMed ID: 11133807)
1. Aberrant expression of hepatocyte growth factor and its receptor, c-Met, during sex hormone-induced prostatic carcinogenesis in the Noble rat.
Tam NN; Chung SS; Lee DT; Wong YC
Carcinogenesis; 2000 Dec; 21(12):2183-91. PubMed ID: 11133807
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma.
Humphrey PA; Zhu X; Zarnegar R; Swanson PE; Ratliff TL; Vollmer RT; Day ML
Am J Pathol; 1995 Aug; 147(2):386-96. PubMed ID: 7639332
[TBL] [Abstract][Full Text] [Related]
3. c-met proto-oncogene expression in benign and malignant human prostate tissues.
Pisters LL; Troncoso P; Zhau HE; Li W; von Eschenbach AC; Chung LW
J Urol; 1995 Jul; 154(1):293-8. PubMed ID: 7539865
[TBL] [Abstract][Full Text] [Related]
4. Aberrant activation of hepatocyte growth factor/MET signaling promotes β-catenin-mediated prostatic tumorigenesis.
Aldahl J; Mi J; Pineda A; Kim WK; Olson A; Hooker E; He Y; Yu EJ; Le V; Lee DH; Geradts J; Sun Z
J Biol Chem; 2020 Jan; 295(2):631-644. PubMed ID: 31819003
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of TRPM-2, MMP-7 and ID-1 during sex hormone-induced prostate carcinogenesis in the Noble rat.
Ouyang XS; Wang X; Lee DT; Tsao SW; Wong YC
Carcinogenesis; 2001 Jun; 22(6):965-73. PubMed ID: 11375906
[TBL] [Abstract][Full Text] [Related]
6. Analysis of glycoconjugate patterns of normal and hormone-induced dysplastic Noble rat prostates, and an androgen-independent Noble rat prostate tumor, by lectin histochemistry and protein blotting.
Chan FL; Choi HL; Ho SM
Prostate; 2001 Jan; 46(1):21-32. PubMed ID: 11170128
[TBL] [Abstract][Full Text] [Related]
7. The prostate gland and prostate carcinogenesis.
Wong YC; Wang YZ; Tam NN
Ital J Anat Embryol; 1998; 103(4 Suppl 1):237-52. PubMed ID: 11315954
[TBL] [Abstract][Full Text] [Related]
8. Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor.
Gmyrek GA; Walburg M; Webb CP; Yu HM; You X; Vaughan ED; Vande Woude GF; Knudsen BS
Am J Pathol; 2001 Aug; 159(2):579-90. PubMed ID: 11485916
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of hepatocyte growth factor and c-Met/HGF receptor in benign and malignant human prostate tissue.
Nakashiro K; Hayashi Y; Oyasu R
Oncol Rep; 2003; 10(5):1149-53. PubMed ID: 12883672
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic switch from paracrine to autocrine role of hepatocyte growth factor in an androgen-independent human prostatic carcinoma cell line, CWR22R.
Nakashiro K; Hara S; Shinohara Y; Oyasu M; Kawamata H; Shintani S; Hamakawa H; Oyasu R
Am J Pathol; 2004 Aug; 165(2):533-40. PubMed ID: 15277227
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor (HGF), HGF activator, and c-Met in synovial tissues in rheumatoid arthritis and osteoarthritis.
Nagashima M; Hasegawa J; Kato K; Yamazaki J; Nishigai K; Ishiwata T; Asano G; Yoshino S
J Rheumatol; 2001 Aug; 28(8):1772-8. PubMed ID: 11508578
[TBL] [Abstract][Full Text] [Related]
12. Localization and functional role of hepatocyte growth factor (HGF) and its receptor c-met in the rat developing cerebral cortex.
Sun W; Funakoshi H; Nakamura T
Brain Res Mol Brain Res; 2002 Jun; 103(1-2):36-48. PubMed ID: 12106690
[TBL] [Abstract][Full Text] [Related]
13. Functional expression of HGF and its receptor in human colorectal cancer.
Otte JM; Schmitz F; Kiehne K; Stechele HU; Banasiewicz T; Krokowicz P; Nakamura T; Fölsch UR; Herzig K
Digestion; 2000; 61(4):237-46. PubMed ID: 10878450
[TBL] [Abstract][Full Text] [Related]
14. Activation of hepatocyte growth factor/MET signaling initiates oncogenic transformation and enhances tumor aggressiveness in the murine prostate.
Mi J; Hooker E; Balog S; Zeng H; Johnson DT; He Y; Yu EJ; Wu H; Le V; Lee DH; Aldahl J; Gonzalgo ML; Sun Z
J Biol Chem; 2018 Dec; 293(52):20123-20136. PubMed ID: 30401749
[TBL] [Abstract][Full Text] [Related]
15. Expression of hepatocyte growth factor/scatter factor and c-Met in human dental papilla and fibroblasts from dental papilla.
Kajihara T; Ohnishi T; Arakaki N; Semba I; Daikuhara Y
Arch Oral Biol; 1999 Feb; 44(2):135-47. PubMed ID: 10206332
[TBL] [Abstract][Full Text] [Related]
16. Met-Independent Hepatocyte Growth Factor-mediated regulation of cell adhesion in human prostate cancer cells.
Tate A; Isotani S; Bradley MJ; Sikes RA; Davis R; Chung LW; Edlund M
BMC Cancer; 2006 Jul; 6():197. PubMed ID: 16869958
[TBL] [Abstract][Full Text] [Related]
17. A novel rabbit anti-hepatocyte growth factor monoclonal neutralizing antibody inhibits tumor growth in prostate cancer cells and mouse xenografts.
Yu Y; Chen Y; Ding G; Wang M; Wu H; Xu L; Rui X; Zhang Z
Biochem Biophys Res Commun; 2015 Aug; 464(1):154-60. PubMed ID: 26093299
[TBL] [Abstract][Full Text] [Related]
18. Expression of c-MET/HGF receptor mRNA and protein in human non-malignant and malignant prostate tissues.
Tsuka H; Mori H; Li B; Kanamaru H; Matsukawa S; Okada K
Int J Oncol; 1998 Nov; 13(5):927-34. PubMed ID: 9772281
[TBL] [Abstract][Full Text] [Related]
19. Involvement of HGF/SF-Met signaling in prostate adenocarcinoma cells: evidence for alternative mechanisms leading to a metastatic phenotype in Pr-14c.
MacDougall CA; Vargas M; Soares CR; Holzer RG; Ide AE; Jorcyk CL
Prostate; 2005 Jul; 64(2):139-48. PubMed ID: 15678502
[TBL] [Abstract][Full Text] [Related]
20. A potential cardioprotective role of hepatocyte growth factor in myocardial infarction in rats.
Ueda H; Nakamura T; Matsumoto K; Sawa Y; Matsuda H; Nakamura T
Cardiovasc Res; 2001 Jul; 51(1):41-50. PubMed ID: 11399246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]